Activity

Activity ID

4874

Expires

September 11, 2023

Format Type

Journal-based CME

CME Credit

1

Fee

$30
CME Provider

JAMA

Description

This Viewpoint reviews what is known about acute and long-term B-cell, antibody, and T-cell responses to SARS-CoV-2 infection and explains how each are implicated in vaccine candidates likely to be effective and durably protective again COVID-19.

Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To understand how B-cell and T-cell mediated adaptive immunity to COVID-19 can help us manage the pandemic

Keywords

Allergy and Clinical Immunology, Infectious Diseases, Pathology and Laboratory Medicine, Coronavirus (COVID19)

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Additional Information

doi: 10.1001/jama.2020.16656

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.